These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1981830)

  • 21. Clinical significance of erbB-2 (HER-2/neu) protein.
    Paik S
    Cancer Invest; 1992; 10(6):575-9. PubMed ID: 1358410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors.
    Visscher DW; Sarkar FH; Crissman JD
    Anal Quant Cytol Histol; 1991 Dec; 13(6):418-24. PubMed ID: 1687240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of c-erbB-2 protein detected in adenocarcinoma arising from parotid pleomorphic adenoma.
    Sugawara K; Mori S; Morita M
    Auris Nasus Larynx; 1990; 17(2):115-20. PubMed ID: 1977376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The c-erbB-2 protein in primary and metastatic breast carcinomas.
    Nesland JM; Ottestad L; Børresen AL; Tvedt KE; Holm R; Heikkilä R; Tveit K
    Ultrastruct Pathol; 1991; 15(3):281-9. PubMed ID: 1678562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of the c-erbB2 gene in human breast cancer.
    Zoll B; Kynast B; Corell B; Marx D; Fischer G; Schauer A
    J Cancer Res Clin Oncol; 1992; 118(6):468-73. PubMed ID: 1352298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
    Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD
    J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
    Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU
    Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.
    King BL; Carter D; Foellmer HG; Kacinski BM
    Am J Pathol; 1992 Jan; 140(1):23-31. PubMed ID: 1346236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
    Heintz NH; Leslie KO; Rogers LA; Howard PL
    Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP; Strickler JG
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HER-2/neu oncogene in breast cancer: so what is new?
    Levine MN; Andrulis I
    J Clin Oncol; 1992 Jul; 10(7):1034-6. PubMed ID: 1351536
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.
    Tsuda H; Hirohashi S; Shimosato Y; Tanaka Y; Hirota T; Tsugane S; Shiraishi M; Toyoshima K; Yamamoto T; Terada M
    Jpn J Cancer Res; 1990 Apr; 81(4):327-32. PubMed ID: 1973161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth factor receptor and related oncogene determination in mesenchymal tumors.
    Duda RB; Cundiff D; August CZ; Wagman LD; Bauer KD
    Cancer; 1993 Jun; 71(11):3526-30. PubMed ID: 8098266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer.
    Nugent A; McDermott E; Duffy K; O'Higgins N; Fennelly JJ; Duffy MJ
    Clin Chem; 1992 Aug; 38(8 Pt 1):1471-4. PubMed ID: 1353709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
    Dean CJ; Allan S; Eccles S; McFarlane C; Styles J; Valeri M; Sandle J; Bakir A; Sacks N
    Year Immunol; 1993; 7():182-92. PubMed ID: 8103950
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays.
    Beckmann MW; Toney LJ; Scharl A; Fuchs-Young R; Greene GL; Holt JA
    Eur J Cancer; 1992; 28(2-3):322-6. PubMed ID: 1350453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.